⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL870716 | 0.67 | — | — | |
| SCHEMBL29424231 | 0.67 | CHEK1 (0.49) | — | |
| SCHEMBL3316685 | 0.67 | — | — | |
| SCHEMBL23731581 | 0.64 | — | — | |
| SCHEMBL30967258 | 0.61 | — | — | |
| SCHEMBL2449272 | 0.61 | — | — | |
| SCHEMBL2992191 | 0.61 | — | — | |
| SCHEMBL30672241 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL25313529 | 0.60 | NNMT (0.46) | — | |
| SCHEMBL4499079 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021220132-A1 | METHODS AND COMPOSITIONS FOR OCULAR CELL THERAPY | NOVARTIS AG (CH) | 2021-11-04 | — | — | WO | disclosed |